Navigation Links
Bringing New Cell Therapies to Market Requires Top-Notch Logistics and Operational Efficiency
Date:1/24/2013


According to Mr. O’Donnell, “To develop a commercially viable cell therapy, companies have to consider packaging, storage, inventory management, monitoring systems, distribution, and even clinical site capabilities from the very beginning. Companies that overlook these issues until clinical trials begin can find that they have inadvertently limited their product’s scalability and commercial viability, or incurred unnecessary costs and complications downstream.”
Following his talk, Mr. O’Donnell will also participate in the round table discussion, “What does a commercially successful cell or gene therapy look like?”

The first breakout session following the plenary talks will address commercially feasible manufacturing and business models. Mr. Simpson, Fisher BioServices’ Director of Commercial Operations, will offer his insights on cold chain transport and building efficiency into operational processes, and will discuss recent case studies for allogeneic vs. autologous therapies. He will then participate in a roundtable discussion focused on minimizing the cost of goods and maximizing efficiency of operations.

About Fisher BioServices
Fisher BioServices has 25 years of experience in biological repository/biobanking services, cold chain logistics, and in supporting clinical trials and public health research. The company manages more than 170,000,000 high value biological specimens, cell-based therapeutics, vaccines, tissues, and sample-related data. Fisher BioServices has cGMP compliant repositories, laboratories, and specimen collection kit production and clinical trial support capabilities, depots, and affiliated sites around the world, and serves more than 20 government and hundreds of commercial clients. Fisher BioServices is part of Thermo Fisher Scientific, Inc., the world leader in serving science.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science. The comp
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ORNL wins 9 R&D 100s, bringing total to 173
2. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
3. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
4. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
5. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
6. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
7. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
8. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
9. CNIO researchers describe a new target for developing anti-angiogenic and anti-tumoral therapies
10. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
11. CSL Biotherapies Awarded US Government Contract for Influenza Pandemic Preparedness and Response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015  Faced with increasing challenges such as ... than symptomatic, the global healthcare industry today is ... of curing or significantly changing the course of ... towards regenerative medicine as a viable alternative. ... human health with the potential to resolve unmet ...
(Date:7/27/2015)... , ... July 27, 2015 , ... Production of high ... the past few years in the EU. For instance, it surpassed the EUR 106 ... 92 million mark in 2010. Germany is a major producer, while Italy is a ...
(Date:7/27/2015)... -- According to the new Market Research Report ... by Application (Biobanking, Regenerative Medicine, Drug Discovery), by Geography ( ... Asia-Pacific , Rest of the World) - ... was valued at $247.7 million in 2014, which is estimated ... CAGR of 18.2% between 2014 and 2019. Browse ...
(Date:7/26/2015)... Cumberland, Maine (PRWEB) , ... July 26, 2015 ... ... the release of its VALIDATE® ANEMIA calibration verification / linearity test kit. The ... matrix. Each VALIDATE® ANEMIA kit is prepared using the CLSI recommended “equal ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2
... , , , , , , ... workstations and is designed to meet the needs , of scientists requiring standardized protocols ... , , , ... , , ...
... , , Part V: Counting cells , ... series of articles providing useful hints for , culturing animal cells. ... , This protocol has been adapted from ... for general cell culture and have not been , rigorously validated ...
... , , , , , , ... USA , , , , , ... PCR* technology has been widely used in molecular biology research, providing , ... sequencing, and PCR cloning for gene expression. However, under standard , ...
Cached Biology Technology:BioRobot MDx standardize your automated protocols in clinical , laboratories 2BioRobot MDx standardize your automated protocols in clinical , laboratories 3BioRobot MDx standardize your automated protocols in clinical , laboratories 4BioRobot MDx standardize your automated protocols in clinical , laboratories 5The QIAGEN Guide to Animal Cell Culture 2The QIAGEN Guide to Animal Cell Culture 3TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 2TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 3TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 4TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 5TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 6TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 7TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 8TripleMaster PCR SystemThe Ideal Choice for Long-Range PCR 9
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Society of Interventional Radiology and Custom Computer Specialists ... agreement to promote innovation and the development of ... radiology. "We are thrilled to have this ... track outcomes and monitor the quality of care ...
... 2005 when he was applying to the PhD program at the ... his host, Brian Bowen, PhD, a biologist at the university, took ... looked under a rock ledge and was startled to see five ... the eels, he found the same fish species in all of ...
... in the northeastern United States are more likely to ... autoimmune disease and vitamin D deficiency, says a new ... Health researcher. In the paper, which appears online ... spatial analysis led by Dr. Vernica Vieira, MS, DSc, ...
Cached Biology News:Society of Interventional Radiology, Custom Computer Specialists announce HI-IQ licensing agreement 2Cosmopolitan eels 2Cosmopolitan eels 3Cosmopolitan eels 4Cosmopolitan eels 5BUSPH study links rheumatoid arthritis to vitamin D deficiency 2
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
... template DNA, primers, salts or other unwanted ... proved critical for both standard and capillary ... with dye terminator cycle sequencing chemistries such ... uniformity of the magnetic paeticles guarantees consistent ...
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Biology Products: